Old Web
English
Sign In
Acemap
>
authorDetail
>
Steve Couvillion
Steve Couvillion
Ranibizumab
Diabetes mellitus
Medicine
Macular edema
Bevacizumab
3
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Intravitreal Perfluoropropane Gas (C3F8) Versus Ocriplasmin for Vitreomacular Traction (VMT)
2015
Investigative Ophthalmology & Visual Science
Nathan Steinle
Dilsher Dhoot
Carlos Quezada
M. Nasir
Dante J. Pieramici
Robert F. See
Steve Couvillion
Alessandro A. Castellarin
Robert L. Avery
Show All
Source
Cite
Save
Citations (0)
Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study)
2015
Eye
Dilsher Dhoot
Dante J. Pieramici
M. Nasir
Alessandro A. Castellarin
Steve Couvillion
Robert F. See
Nathan Steinle
Michael Bennett
Melvin Rabena
Robert L. Avery
Show All
Source
Cite
Save
Citations (28)
Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab
2013
Investigative Ophthalmology & Visual Science
Dante J. Pieramici
M. Nasir
Alessandro A. Castellarin
Robert F. See
Steve Couvillion
Michael Bennett
Melvin Rabena
Jack Giust
Lisha Wan
Robert A. Avery
Show All
Source
Cite
Save
Citations (0)
1